Table 1.
Demographic Characteristics of Participants
| Characteristics | C group (n = 44) | NC group (n = 44) | P value |
|---|---|---|---|
| Age (y) | 51.02 ± 9.11 | 50.68 ± 9.01 | .861 |
| Gender | 28M, 16F | 28M, 16F | 1 |
| Sex ratio (M:F) | 1.6:1 | 1.6:1 | 1 |
| BMI (kg/m2) | 23.66 ± 2.94 | 24.39 ± 2.45 | .213 |
| Weight (kg) | 65.84 ± 10.14 | 66.92 ± 9.32 | .606 |
| PANSS | 67.55 ± 5.27 | 67.69 ± 2.69 | .960 |
| CD (y) | 24.89 ± 9.43 | 22.27 ± 9.93 | .212 |
| CAS | 2.32 ± 2.59 | 0.61 ± 0.95 | <.05* |
| BSS | 2.45 ± 1.37 | 4.02 ± 1.09 | <.05* |
| ROM | 0.55 ± 0.50 | 0.25 ± 0.44 | <.05* |
| EDC (mg) | 480.45 ± 248.50 | 434.89 ± 247.98 | .394 |
| Duration of drug use (mo) | 20.20 ± 21.51 | 26.80 ± 28.62 | .229 |
| Diabetes | 31.8% | 20.5% | .229 |
| Hypertension | 22.7% | 29.5% | .472 |
| Smokers | 31.8% | 45.5% | .193 |
Note: Data are presented as mean ± standard deviation. C, patients with constipation; NC, patients without constipation; M, male; F, female; BMI, Body Mass Index; CAS, Constipation Assessment Scale; BSS, Bristol Stool Form Scale;ROM, radiopaque marker; EDC, equivalent dose of clozapine; PANSS, Positive and Negative Syndrome Scale; CD, course of the disease.